01 / Contract Profile
75A50122C00081 Federal Contract Award
Agency code 7505
VIR BIOTECHNOLOGY - OTA FOR PRE-EXPOSURE PROPHYLACTIC MONOCLONAL ANTIBODIES FOR THE PREVENTION OF INFLUENZA ILLNESS AND MEDICAL COUNTERMEASURES FOR OTHER EMERGING PATHOGENS OF PANDEMIC POTENTIAL
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
75A50122C00081 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations-$8.36M
FY 2025Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2022 | $55.00M | 1 | — |
| FY 2023 | $61.30M | 1 | +11.5% |
| FY 2024 | -$42.07M | 2 | −168.6% |
| FY 2025 | -$8.36M | 1 | +80.1% |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | BARDA - ASPR / DAAPPO / BARDA DCMA |
05 / Contractor
Who holds this federal contract?
VIR BIOTECHNOLOGY, INC.
UEI VAGNEFK9N5X7 · CAGE 80UV6
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $65.87M | 5 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN11 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $65.87M | 5 | 100.0% |
08 / Place of Performance
Where is the work recorded?
SAN FRANCISCO, SAN FRANCISCO, CALIFORNIA, UNITED STATES
ZIP 941582552
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Aug 5, 2025 | P00004 | -$8.36M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN11 |
| Sep 9, 2024 | P00003 | -$42.07M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN11 |
| Jan 18, 2024 | P00002 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN11 |
| Sep 28, 2023 | P00001 | $61.30M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN11 |
| Sep 28, 2022 | Base action | $55.00M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN11 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.